Products for Research Use Only
RegisterLogin

Grisnilimab

CAT: 0804-HY-P99650-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99650-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Grisnilimab (WT1), a IgG2a monoclonal antibody anti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA[1].
CAS Number
2367001-70-3
Product Name Alternative
WT1
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/grisnilimab.html
Purity
99.43
Solubility
10 mM in DMSO
Smiles
[Grisnilimab]
Molecular Weight
(146.39 kDa)
References & Citations
[1]Scharnhorst V, et al. WT1 proteins: functions in growth and differentiation. Gene. 2001 Aug 8;273 (2) :141-61.|[2]Hertler AA, et al. An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys. Cancer Immunol Immunother. 1989;28 (1) :59-66.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
591904Grisnilimab
MBS5823911Grisnilimab setaritox
GTR18333509-01Grisnilimab Antibody
MBS1563470-01Research Grade Grisnilimab
A2834-01Grisnilimab (Anti-CD7)
E55B0794Grisnilimab (Reference antibody)
048138CD7 (grisnilimAb) discontinued
GTR18333510-01Grisnilimab setaritox Antibody
ICH5584-20mgGrisnilimab Biosimilar - Research Grade
F1472-50Anti-CD7 Antibody (GrisnilimAb)

Popular Products